Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition M Tarrado-Castellarnau, R Cortes, M Zanuy, J Tarragó-Celada, IH Polat, ... Pharmacological research 102, 218-234, 2015 | 63 | 2015 |
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition M Tarrado‐Castellarnau, P de Atauri, J Tarragó‐Celada, J Perarnau, ... Molecular systems biology 13 (10), 940, 2017 | 60 | 2017 |
Cysteine and folate metabolism are targetable vulnerabilities of metastatic colorectal cancer J Tarragó-Celada, C Foguet, M Tarrado-Castellarnau, S Marin, ... Cancers 13 (3), 425, 2021 | 20 | 2021 |
Tracing metabolic fluxes using mass spectrometry: Stable isotope-resolved metabolomics in health and disease C Balcells, C Foguet, J Tarrago-Celada, P de Atauri, S Marin, M Cascante TrAC Trends in Analytical Chemistry 120, 115371, 2019 | 18 | 2019 |
The importance of post-translational modifications in systems biology approaches to identify therapeutic targets in cancer metabolism A Martín-Bernabé, C Balcells, J Tarragó-Celada, C Foguet, ... Current Opinion in Systems Biology 3, 161-169, 2017 | 18 | 2017 |
Targeting the metabolic adaptation of metastatic cancer J Tarragó-Celada, M Cascante Cancers 13 (7), 1641, 2021 | 11 | 2021 |
Quantitative proteomic approach reveals altered metabolic pathways in response to the inhibition of lysine deacetylases in a549 cells under normoxia and hypoxia A Martín-Bernabé, J Tarragó-Celada, V Cunin, S Michelland, R Cortes, ... International Journal of Molecular Sciences 22 (7), 3378, 2021 | 6 | 2021 |
Software supporting a workflow of quantitative dynamic flux maps estimation in central metabolism from SIRM experimental data VA Selivanov, S Marin, J Tarragó-Celada, AN Lane, RM Higashi, ... Metabolic Flux Analysis in Eukaryotic Cells: Methods and Protocols, 271-298, 2020 | 5 | 2020 |
Integrating systemic and molecular levels to infer key drivers sustaining metabolic adaptations P de Atauri, M Tarrado-Castellarnau, J Tarragó-Celada, C Foguet, ... PLoS Computational Biology 17 (7), e1009234, 2021 | 2 | 2021 |
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells M Tarrado-Castellarnau, C Foguet, J Tarragó-Celada, M Palobart, ... bioRxiv, 2024.01. 04.574237, 2024 | | 2024 |
Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction E Zodda, O Tura-Ceide, NL Mills, J Tarragó-Celada, M Carini, ... Elife 12, e86260, 2023 | | 2023 |
Endothelial dysfunction in acute myocardial infarction: cell-autonomous metabolic reprogramming and oxidative stress. E Zodda, O Tura-Ceide, NL Mills, J Tarragó-Celada, M Carini, ... Elife 12, e86260-e86260, 2023 | | 2023 |
Cell-autonomous metabolic reprogramming and oxidative stress underlie endothelial dysfunction in acute myocardial infarction E Zodda, O Tura-Ceide, NL Mills, J Tarragó-Celada, M Carini, ... bioRxiv, 2023.02. 28.530418, 2023 | | 2023 |
Integrating systemic and molecular levels to infer key drivers sustaining metabolic adaptations R Atauri Carulla, MN Tarrado Castellarnau, J Tarragó-Celada, ... PLoS Computational Biology, 2021, vol. 17, num. 7, p. e1009234, 2021 | | 2021 |
Targeting the Metabolic Adaptation of Metastatic Cancer. Cancers 2021, 13, 1641 J Tarragó-Celada, M Cascante s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
Study of the metabolic reprogramming associated to metastasis in colon cancer JT Celada Universitat de Barcelona, 2020 | | 2020 |
Supplementary dataset for journal article" De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition" M Tarrado‐Castellarnau, P Atauri, J Tarragó‐Celada, J Perarnau, ... Zenodo, 2017 | | 2017 |
8.4 Chapter 4 Cysteine and folate metabolism are major vulnerabilities of the metastatic subpopulations of colorectal cancer J Tarragó-Celada, C Foguet, J Perarnau Development of model-driven approaches for metabolic flux analysis and …, 0 | | |